piracetam has been researched along with Fibromyalgia in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Fibromyalgia: A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)
Excerpt | Relevance | Reference |
---|---|---|
"Erythrocyte transketolase activity coefficient (ETK-AC) and affinity for coenzyme (Km TPP) were assessed in 50 patients with transketolase abnormalities such as fibromyalgia or senile dementia of Alzheimer's type, before and after magnesium (Mg), thiamin+pyridoxine (B1,B6), high energy phosphates (HEP) (phosphocreatinine of adenosine triphosphate), and piracetam." | 3.69 | Effects of magnesium, high energy phosphates, piracetam and thiamin on erythrocyte transketolase. ( Arroyo, P; Ayavou, T; Bagneres, D; Eisinger, J; Plantamura, A, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Üçeyler, N | 2 |
Sommer, C | 2 |
Walitt, B | 2 |
Häuser, W | 2 |
Eisinger, J | 1 |
Bagneres, D | 1 |
Arroyo, P | 1 |
Plantamura, A | 1 |
Ayavou, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Cannabidiol for Fibromyalgia -The CANNFIB Trial Protocol for a Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-center Trial[NCT04729179] | Phase 3 | 200 participants (Anticipated) | Interventional | 2021-03-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for piracetam and Fibromyalgia
Article | Year |
---|---|
WITHDRAWN: Anticonvulsants for fibromyalgia.
Topics: Acetamides; Amines; Anticonvulsants; Conflict of Interest; Cyclohexanecarboxylic Acids; Fibromyalgia | 2017 |
Anticonvulsants for fibromyalgia.
Topics: Acetamides; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Fibromyalgia; Gabapentin; gamma-Am | 2013 |
1 other study available for piracetam and Fibromyalgia
Article | Year |
---|---|
Effects of magnesium, high energy phosphates, piracetam and thiamin on erythrocyte transketolase.
Topics: Adenosine Triphosphate; Aged; Aged, 80 and over; Alzheimer Disease; Erythrocytes; Female; Fibromyalg | 1994 |